MINARI, Roberta

MINARI, Roberta  

Dipartimento di Medicina Clinica e Sperimentale (attivo dal 20/07/2012 al 31/12/2016)  

Mostra records
Risultati 1 - 20 di 27 (tempo di esecuzione: 0.09 secondi).
Titolo Data di pubblicazione Autore(i) File
1352P A highly predictive blood-radiomics classifier in advanced NSCLC treated with immunotherapy 1-gen-2021 Mazzaschi, G.; Scandino, R.; Milanese, G.; Pavone, C.; Maurizio, B.; Silva, M.; Ledda, R.; Minari, R.; Trentini, F.; Buti, S.; Bordi, P.; Leonetti, A.; Quaini, F.; Sverzellati, N.; Romanel, A.; Tiseo, M.
17P Dynamic changes of CT-radiomic and systemic immune-inflammatory features predict the response to immune checkpoint inhibitors in advanced NSCLC patients 1-gen-2021 Mazzaschi, G.; Milanese, G.; Moron Dalla Tor, L.; Leo, L.; Balbi, M.; Trentini, F.; Manini, M.; Pavone, C.; Silva, M.; Ledda, R. E.; Minari, R.; Bordi, P.; Buti, S.; Leonetti, A.; Roti, G.; Quaini, F.; Sverzellati, N.; Tiseo, M.
Combination of EGFR-TKIs and chemotherapy in advanced EGFR mutated NSCLC: review of the literature and future perspectives 1-gen-2020 Rebuzzi, Sara Elena; Alfieri, Roberta; La Monica, Silvia; Minari, Roberta; Petronini, Pier Giorgio; Tiseo, Marcello
Concurrent Acquired BRAF V600E Mutation and MET Amplification as Resistance Mechanism of First-Line Osimertinib Treatment in a Patient with EGFR-Mutated NSCLC 1-gen-2018 Minari, Roberta; Bordi, Paola; La Monica, Silvia; Squadrilli, Anna; Leonetti, Alessandro; Bottarelli, Lorena; Azzoni, Cinzia; Lagrasta, Costanza Anna Maria; Gnetti, Letizia; Campanini, Nicoletta; Petronini, Pier Giorgio; Alfieri, Roberta; Tiseo, Marcello
Detection of EGFR-Activating and T790M Mutations Using Liquid Biopsy in Patients With EGFR-Mutated Non–Small-Cell Lung Cancer Whose Disease Has Progressed During Treatment With First- and Second-Generation Tyrosine Kinase Inhibitors: A Multicenter Real-Life Retrospective Study 1-gen-2020 Minari, R.; Mazzaschi, G.; Bordi, P.; Gnetti, L.; Alberti, G.; Altimari, A.; Gruppioni, E.; Sperandi, F.; Parisi, C.; Guaitoli, G.; Bettelli, S.; Longo, L.; Bertolini, F.; Pagano, M.; Bonelli, C.; Tagliavini, E.; Nicoli, D.; Ubiali, A.; Zangrandi, A.; Trubini, S.; Proietto, M.; Fiorentino, M.; Tiseo, M.
Dynamic evolution of blood immune-inflammatory descriptors in advanced non-small cell lung cancer undergoing first-line immunotherapy-based regimens 1-gen-2022 Mazzaschi, G; Verze, M; Tognazzi, D; Lorusso, B; Minari, R; Pluchino, M; Trentini, F; Manini, M; Bordi, P; Leonetti, A; Perrone, F; Coriano, M; Casali, M; Toscani, I; Cosenza, A; Ferri, L; Buti, S; Sverzellati, N; Quaini, F; Tiseo, M
Efficacy of the cdk4/6 dual inhibitor abemaciclib in egfr-mutated nsclc cell lines with different resistance mechanisms to osimertinib 1-gen-2021 LA Monica, S.; Fumarola, C.; Cretella, D.; Bonelli, M.; Minari, R.; Cavazzoni, A.; Digiacomo, G.; Galetti, M.; Volta, F.; Mancini, M.; Petronini, P. G.; Tiseo, M.; Alfieri, R.
Emergence of a HER2-amplified clone during disease progression in an ALK-rearranged NSCLC patient treated with ALK-inhibitors: A case report 1-gen-2020 Minari, R.; Gnetti, L.; Lagrasta, C. A.; Squadrilli, A.; Bordi, P.; Azzoni, C.; Bottarelli, L.; Cosenza, A.; Ferri, L.; Caruso, G.; Silini, E. M.; Tiseo, M.
Evidence fo Epigenetic Abnormalities of the Androgen Receptor Gene in Foreskin from Children with Hypospadias 1-gen-2011 Vottero, Alessandra; Minari, Roberta; Viani, Isabella; F., Tassi; Bonatti, Francesco; Neri, Tauro Maria; Bertolini, Lorenzo; Bernasconi, Sergio; Ghizzoni, Lucia
Expanding the Arsenal of FGFR Inhibitors: A Novel Chloroacetamide Derivative as a New Irreversible Agent With Anti-proliferative Activity Against FGFR1-Amplified Lung Cancer Cell Lines. 1-gen-2019 Fumarola, C; Bozza, N; Castelli, R; Ferlenghi, F; Marseglia, Giuseppe; Lodola, A; Bonelli, M; La Monica, S; Cretella, D; Alfieri, R; Minari, R; Galetti, M; Tiseo, M; Ardizzoni, A; Mor, M; Petronini, Pg.
From the beginning to resistance: Study of plasma monitoring and resistance mechanisms in a cohort of patients treated with osimertinib for advanced T790M-positive NSCLC 1-gen-2019 Bordi, P.; Del Re, M.; Minari, R.; Rofi, E.; Buti, S.; Restante, G.; Squadrilli, A.; Crucitta, S.; Casartelli, C.; Gnetti, L.; Azzoni, C.; Bottarelli, L.; Petrini, I.; Cosenza, A.; Ferri, L.; Rapacchi, E.; Danesi, R.; Tiseo, M.
It Takes Two to Tango: Potential Prognostic Impact of Circulating TGF-Beta and PD-L1 in Pancreatic Cancer 1-gen-2022 Garajová, Ingrid; Cavazzoni, Andrea; Verze, Michela; Minari, Roberta; Pedrazzi, Giuseppe; Balsano, Rita; Gelsomino, Fabio; DALLA VALLE, Raffaele; Digiacomo, Graziana; Giovannetti, Elisa; Leonardi, Francesco
L718Q Mutation as New Mechanism of Acquired Resistance to AZD9291 in EGFR-Mutated NSCLC 1-gen-2016 Bersanelli, Melissa; Minari, Roberta; Bordi, Paola; Gnetti, Letizia; Bozzetti, Cecilia; Squadrilli, Anna; Lagrasta, Costanza Anna Maria; Bottarelli, Lorena; Osipova, Ganna; Capelletto, Enrica; Mor, Marco; Tiseo, Marcello
LONGITUDINAL MONITORING OF RADIOMIC AND BLOOD IMMUNE-INFLAMMATORY DESCRIPTORS AS A NON-INVASIVE APPROACH TO PREDICT ICI EFFICACY IN ADVANCED NSCLC PATIENTS 1-gen-2022 Mazzaschi, G; Moron Dalla Tor, L; Balbi, M; Milanese, G; Leo, L; Dalla Valle, B; Trentini, F; Lorusso, B; Verzè, M; Pluchino, M; Minari, R; Perrone, F; Bordi, P; Leonetti, A; Buti, S; Silva, M; Roti, G; Sverzellati, N; Quaini, F; Tiseo, M
Modulating Tumor Microenvironment: A Review on STK11 Immune Properties and Predictive vs Prognostic Role for Non-small-cell Lung Cancer Immunotherapy 1-gen-2021 Mazzaschi, G.; Leonetti, A.; Minari, R.; Gnetti, L.; Quaini, F.; Tiseo, M.; Facchinetti, F.
A novel mutation in the nr0b1 gene in a family with monozygotic twin sisters and congenital adrenal hypoplasia affected children. 1-gen-2015 Minari, Roberta; Vottero, Alessandra; F., Tassi; Viani, Isabella; T. M., Neri; Street, Maria Elisabeth; Ghizzoni, Lucia; Bernasconi, Sergio; D., Martorana
Oncogene addiction in non-small cell lung cancer: Focus on ROS1 inhibition 1-gen-2017 Facchinetti, Francesco; Rossi, Giulio; Bria, Emilio; Soria, Jean-Charles; Besse, Benjamin; Minari, Roberta; Friboulet, Luc; Tiseo, Marcello
P1.15-04 Dynamic Profiling of Blood Immunophenotypes and Radiomic Features to Predict Immunotherapy Response in Advanced Non-small Cell Lung Cancer 1-gen-2022 Mazzaschi, G.; Moron Dalla Tor, L.; Milanese, G.; Balbi, M.; Tognazzi, D.; Lorusso, B.; Verzè, M.; Pluchino, M.; Minari, R.; Leo, L.; Ledda, R. E.; Bordi, P.; Leonetti, A.; Buti, S.; Roti, G.; Quaini, F.; Sverzellati, N.; Tiseo, M.
PD-L1 SNPs as biomarkers to define benefit in patients with advanced NSCLC treated with immune checkpoint inhibitors 1-gen-2021 Minari, R.; Bonatti, F.; Mazzaschi, G.; Dodi, A.; Facchinetti, F.; Gelsomino, F.; Cinquegrani, G.; Squadrilli, A.; Bordi, P.; Buti, S.; Bersanelli, M.; Leonetti, A.; Cosenza, A.; Ferri, L.; Rapacchi, E.; Quaini, F.; Ardizzoni, A.; Tiseo, M.
Phase II, Open-label, Single-arm, Multicenter Study to Assess the Activity and Safety of Alectinib as Neoadjuvant Treatment in Surgically Resectable Stage III ALK-positive NSCLC: ALNEO Trial 1-gen-2021 Leonetti, A.; Minari, R.; Boni, L.; Gnetti, L.; Verze, M.; Ventura, L.; Musini, L.; Tognetto, M.; Tiseo, M.